Michael Thomas Heffernan - Insider Trading & Ownership

Entity: Individual
Location: C/O Cornerstone Therapeutics Inc., 1255 Crescent Green Drive, Suite 250, Cary, NC
Summary: The estimated net worth of Michael Thomas Heffernan is at least $1.6M dollars as of March 26, 2025. Michael Thomas Heffernan is the Director of COLLEGIUM PHARMACEUTICAL, INC and owns shares of COLLEGIUM PHARMACEUTICAL, INC (COLL) stock worth about $1.54M. Michael Thomas Heffernan is the Director of Akebia Therapeutics, Inc. and owns shares of Akebia Therapeutics, Inc. (AKBA) stock worth about $59.4K.
All Insider Reports: All Insider Reports

Ownership of Michael Thomas Heffernan

Symbol	Company	Relationship	Holdings Value	Report Period
COLL	COLLEGIUM PHARMACEUTICAL, INC	Director	$1.54M	Feb 10, 2025
AKBA	Akebia Therapeutics, Inc.	Director	$59.4K	Jun 2, 2021
AVTX	Avalo Therapeutics, Inc.	Director		Mar 25, 2025
BHVN	Biohaven Ltd.	Director		Apr 30, 2024
BHVN	Biohaven Pharmaceutical Holding Co Ltd.	Director		Oct 3, 2022
SYBX	SYNLOGIC, INC.	Director		Jun 22, 2023
TRVI	Trevi Therapeutics, Inc.	Director		Jun 13, 2024

Showing 1 to 7 of 7 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.